Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Fletcher

Showing results (151-160 of 161) with videos related to

Pageof 17
Sort By:
Journal of Acquired Immune Deficiency Syndromes|January 1, 1989
Seroepidemiologic studies of cytomegalovirus and Epstein-Barr virus infections in relation to human immunodeficiency virus type 1 infection in selected recipient populations. Transfusion Safety Study GroupD J Lang, A A Kovacs, J A Zaia, et al.
Annals of Internal Medicine|November 15, 1990
Infection with human immunodeficiency virus type 1 (HIV-1) among recipients of antibody-positive blood donationsE Donegan, M Stuart, J C Niland, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1978
Inhibition of growth and guanylate cyclase activity of an undifferentiated prostate adenocarcinoma by an extract of the balsam pear (Momordica charantia abbreviata)A J Claflin, D L Vesely, J L Hudson, et al.
Blood|September 1, 1994
Effect of low- and intermediate-purity clotting factor therapy on progression of human immunodeficiency virus infection in congenital clotting disorders. Transfusion Safety Study GroupG F Gjerset, M C Pike, J W Mosley, et al.
Blood|August 15, 1993
Effect on lymphocyte subsets of clotting factor therapy in human immunodeficiency virus-1-negative congenital clotting disorders. The Transfusion Safety Study GroupJ Hassett, G F Gjerset, J W Mosley, et al.
American Journal of Public Health|February 1, 1990
HIV seropositivity of needles from shooting galleries in south FloridaD D Chitwood, C B McCoy, J A Inciardi, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 26, 2007
Reduction in pediatric invasive pneumococcal disease in the Basque Country and Navarre, Spain, after introduction of the heptavalent pneumococcal conjugate vaccineJ Aristegui, E Bernaola, I Pocheville, et al.
AIDS Research and Human Retroviruses|February 10, 1996
Intrathecal synthesis of anti-sulfatide IgG is associated with peripheral nerve disease in acquired immunodeficiency syndromeR De Gasperi, M Angel, G Sosa, et al.
Clinical and Diagnostic Laboratory Immunology|May 30, 1998
A bereavement support group intervention is longitudinally associated with salutary effects on the CD4 cell count and number of physician visitsK Goodkin, D J Feaster, D Asthana, et al.
Medicine and Science in Sports and Exercise|July 23, 1999
Cardiopulmonary and CD4 cell changes in response to exercise training in early symptomatic HIV infectionF M Perna, A LaPerriere, N Klimas, et al.
Pageof 17

Showing results (151-160 of 161) with videos related to

Sort By:
Pageof 17
Journal of Acquired Immune Deficiency Syndromes|January 1, 1989
Seroepidemiologic studies of cytomegalovirus and Epstein-Barr virus infections in relation to human immunodeficiency virus type 1 infection in selected recipient populations. Transfusion Safety Study GroupD J Lang, A A Kovacs, J A Zaia, et al.
Annals of Internal Medicine|November 15, 1990
Infection with human immunodeficiency virus type 1 (HIV-1) among recipients of antibody-positive blood donationsE Donegan, M Stuart, J C Niland, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1978
Inhibition of growth and guanylate cyclase activity of an undifferentiated prostate adenocarcinoma by an extract of the balsam pear (Momordica charantia abbreviata)A J Claflin, D L Vesely, J L Hudson, et al.
Blood|September 1, 1994
Effect of low- and intermediate-purity clotting factor therapy on progression of human immunodeficiency virus infection in congenital clotting disorders. Transfusion Safety Study GroupG F Gjerset, M C Pike, J W Mosley, et al.
Blood|August 15, 1993
Effect on lymphocyte subsets of clotting factor therapy in human immunodeficiency virus-1-negative congenital clotting disorders. The Transfusion Safety Study GroupJ Hassett, G F Gjerset, J W Mosley, et al.
American Journal of Public Health|February 1, 1990
HIV seropositivity of needles from shooting galleries in south FloridaD D Chitwood, C B McCoy, J A Inciardi, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|April 26, 2007
Reduction in pediatric invasive pneumococcal disease in the Basque Country and Navarre, Spain, after introduction of the heptavalent pneumococcal conjugate vaccineJ Aristegui, E Bernaola, I Pocheville, et al.
AIDS Research and Human Retroviruses|February 10, 1996
Intrathecal synthesis of anti-sulfatide IgG is associated with peripheral nerve disease in acquired immunodeficiency syndromeR De Gasperi, M Angel, G Sosa, et al.
Clinical and Diagnostic Laboratory Immunology|May 30, 1998
A bereavement support group intervention is longitudinally associated with salutary effects on the CD4 cell count and number of physician visitsK Goodkin, D J Feaster, D Asthana, et al.
Medicine and Science in Sports and Exercise|July 23, 1999
Cardiopulmonary and CD4 cell changes in response to exercise training in early symptomatic HIV infectionF M Perna, A LaPerriere, N Klimas, et al.
Pageof 17